What is Avanos Medical's remainder of fiscal year 2025?

Avanos Medical (AVNS) reported remainder of fiscal year 2025 of $14M in Q1 2026.

How has Avanos Medical's remainder of fiscal year 2025 changed year-over-year?

Avanos Medical's remainder of fiscal year 2025 decreased by 31.7% year-over-year, from $20.5M to $14M.

Avanos Medical AVNS Remainder of Fiscal Year 2025

Remainder of Fiscal Year 2025 at other companies

Pacira BioSciences, Inc.PCRX

——

MedtronicMDT

——

Collegium Pharmaceutical, Inc.COLL

——

IAR

Integra LifeSciencesIART

——

Globus MedicalGMED

——

ITG

Integer HoldingsITGR

——

Other financials

Income statement

See full

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

See full

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

See full

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

See full

Market cap$1.17B+108%

Enterprise value$1.24B+105%

P/S1.6×+0.8×

Profitability

See full

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

See full

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's remainder of fiscal year 2025.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avanos Medical's remainder of fiscal year 2025?: Avanos Medical (AVNS) reported remainder of fiscal year 2025 of $14M in Q1 2026.
How has Avanos Medical's remainder of fiscal year 2025 changed year-over-year?: Avanos Medical's remainder of fiscal year 2025 decreased by 31.7% year-over-year, from $20.5M to $14M.